DiabetesNow combines testing for 16 genes associated with monogenic forms of diabetes—including MODY, neonatal, syndromic, and mitochondrial types—with polygenic risk scores (PRS) for type 1 and type ...
Nucleai, a spatial AI company with U.S. headquarters at Chicago's Fulton Labs, is partnering with Buffalo Grove clinical research and diagnostics company GoPath Diagnostics to train its AI for use in ...
OncoTarget® 500 is powered by PGDx Elio Tissue Complete and assesses cancer pathology by analyzing over 500 genes to detect genetic alterations associated with cancer growth. OncoTarget®500 genomic ...
GoPath Diagnostics has obtained a clinical laboratory license from the New York State Department of Health, allowing the company to perform its ProstateNow™ test in addition to its existing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results